Internal Medicine, Gastroenterology · Slidell, LA
NPI
1245292515
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
58515 Pearl Acres Rd
Slidell, LA, 70461
Phone (985) 641-8982
Groups this clinician bills Medicare through
Medicare paid, 2024
$235K
9,181 services
Medicare patients, 2024
421
Average age 73
Drug cost, 2024
$1.9M
2,934 prescriptions
Company payments, 2025
$2,543
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Veronica T Dugan was code 99214 (office e&m - established), 246 times for 174 patients. In total Veronica T Dugan billed 9,181 services in 47 codes, and Medicare paid $235K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 246 | 174 | $84.80 | $21K |
| 43239 Upper GI Endoscopy | Facility | 120 | 114 | $83.57 | $10K |
| 45385 Colonoscopy - Lesion Removal | Facility | 88 | 87 | $171.73 | $15K |
| 43450 Digestive/Gastrointestinal | Facility | 74 | 70 | $29.44 | $2,179 |
| 99223 Hospital E&M - Initial | Facility | 74 | 71 | $127.67 | $9,448 |
| 99204 Office E&M - New | Office | 63 | 63 | $103.29 | $6,507 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 62 | 15 | $46.51 | $2,884 |
| 99215 Office E&M - Established | Office | 57 | 41 | $100.85 | $5,748 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 41 | 14 | $35.42 | $1,452 |
| 45380 Lower GI Endoscopy - Other | Facility | 41 | 41 | $82.95 | $3,401 |
| 91065 Test - Miscellaneous | Office | 30 | 13 | $51.63 | $1,549 |
| 99233 Hospital E&M - Subsequent | Facility | 24 | 22 | $88.68 | $2,128 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 18 | 18 | $170.36 | $3,066 |
| 45388 Lower GI Endoscopy - Other | Facility | 16 | 16 | $191.48 | $3,064 |
| 99205 Office E&M - New | Office | 15 | 15 | $148.46 | $2,227 |
By year: 2022 $83K for 1,208 services; 2023 $142K for 3,331 services; 2024 $235K for 9,181 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 55 | 23 | $24.67 | $1,357 |
| 88313 Surgical Pathology Examination | 31 | 13 | $49.95 | $1,549 |
Medicare prescription drug claims, 2024
In 2024, the drug Veronica T Dugan prescribed most often to Medicare patients was Pantoprazole Sodium, with 787 prescriptions and refills. In total Veronica T Dugan wrote 2,934 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 787 | 1,491 | 241 | $6,280 |
| Linzess Linaclotide | 217 | 311 | 71 | $164K |
| Dicyclomine Hcl Generic | 158 | 162 | 68 | $1,710 |
| Ondansetron Odt Ondansetron | 152 | 152 | 72 | $1,804 |
| Omeprazole Generic | 129 | 284 | 46 | $1,424 |
| Lubiprostone Generic | 117 | 156 | 57 | $11K |
| Dexlansoprazole Dr Dexlansoprazole | 84 | 156 | 21 | $25K |
| Esomeprazole Magnesium Generic | 82 | 195 | 26 | $3,089 |
| Lactulose Generic | 68 | 88 | 45 | $537 |
| Famotidine Generic | 67 | 147 | 24 | $1,110 |
| Sucraid Sacrosidase | 67 | 67 | 18 | $860K |
| Sucralfate Generic | 50 | 59 | 19 | $1,697 |
| Xifaxan Rifaximin | 46 | 50 | 16 | $142K |
| Movantik Naloxegol Oxalate | 43 | 43 | 11 | $17K |
| Promethazine Hcl Generic | 42 | 42 | 11 | $229 |
Brand drugs: - claims; generic drugs: 2,175 claims; opioid claims: 12.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Veronica T Dugan $2,543 ($2,543 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $912.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 84 | $912 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 17 | $227 |
| Janssen Biotech, Inc. JNJ | 10 | $161 |
| Gilead Sciences, Inc. GILD | 5 | $141 |
| Celltrion USA Inc. 068270.KS | 8 | $140 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $120 |
| Genzyme Corporation SNY | 4 | $87.28 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 4 | $83.75 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 5 | $83.31 |
| Pfizer Inc. PFE | 4 | $81.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.